The Royal Wolverhampton NHS Trust

Specialist MDT: University Hospitals of North Midlands NHS Trust

View Provider Services

The following services are available at this hospital trust (updated 2021). Men diagnosed at this trust may be able to access additional services from other trusts within the specialist multidisciplinary team:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under general anaesthetic
    • Transrectal ultrasound (TRUS) biopsy
    • Whole body MRI
    • Isotope bone scan
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Stereotactic body radiation therapy (SBRT)
    • Chemotherapy
    • Clinical trials unit
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Specialist continence services
    • Psychological counselling

Data Quality

For these results, data for England were provided for 1st April 2019 to 31st March 2020 from the Rapid Cancer Registration Dataset (RCRD), which is sourced mainly from the Cancer Services and Outcomes Dataset (COSD) containing proxy tumour registrations, as the standard Cancer Registration data were unavailable. More details can be found here.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 511 2223
Performance Status recorded 59% 59%
TNM completed 39% 44%
Stage variable assigned 98% 66%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 1239 34801
Percentage of men diagnosed with metastatic disease 9% 13%

Management

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on PSA and Gleason score in the Rapid Cancer Registration Dataset

Outcome

Treatment Centre
No. of men who received radical prostatectomy (2019-2020) 161
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 7%
No. of men who received radical prostatectomy (2018) 97
Adjusted percentage of men experiencing at least one GU complication (%) 2%
No. of men who received radical radiotherapy (2018) 118
Adjusted percentage of men receiving a procedure of the large bowel and a diagnosis indicating radiation toxicity (GI complication) (%) 12%

Compare provider outcomes